Savara Pharmaceuticals Obtains $4,493,581 New Funding Round

  • Feed Type
  • Date
    6/11/2014
  • Company Name
    Savara Pharmaceuticals
  • Mailing Address
    900 S. Capital of Texas Highway Austin, TX 78746 USA
  • Company Description
    Savara is a pharmaceutical company developing novel respiratory therapeutics utilizing our proprietary NanoCluster dry powder aerosol drug delivery platform.The aerosols are assembled directly from nanoparticles of an existing therapeutic and delivered via oral pulmonary or nasal routes using off-the-shelf dry powder inhalers.
  • Website
    http://www.savarapharma.com
  • Transaction Type
    Debt
  • Transaction Amount
    $4,493,581
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy